Evidence map›Paper›PMID 32391587›Full record

ArticleInternational journal of cancer2020

Association of prediagnostic vitamin D status with mortality among colorectal cancer patients differs by common, inherited vitamin D-binding protein isoforms.

David Corley Gibbs, Roberd M Bostick, Marjorie L McCullough, Caroline Y Um, W Dana Flanders, Mazda Jenab, Elisabete Weiderpass, Björn Gylling, Inger T Gram, Alicia K Heath and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Prediagnostic 25-Hydroxyvitamin D in Association with Cancer-specific and All-cause Mortality among Low-income, Non-Hispanic Black Americans with Colorectal Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 13 institutions in 11 countries.

David Corley GibbsDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.ORCID 0000-0001-7813-6272
Roberd M BostickDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Marjorie L McCulloughBehavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia, USA.
Caroline Y UmBehavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia, USA.
W Dana FlandersDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
Mazda JenabSection of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), Lyon, France.
Elisabete WeiderpassIARC-WHO, Lyon, France.ORCID 0000-0003-2237-0128
Björn GyllingDepartment of Medical Biosciences, Pathology, Umea University, Umea, Sweden.
Inger T GramFaculty of Health Sciences, Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
Alicia K HeathDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
Sandra Colorado-YoharDepartment of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
Christina C DahmDepartment of Public Health, Aarhus University, Aarhus, Denmark.
Bas Bueno-de-MesquitaDepartment for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Aurora Perez-CornagoCancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Antonia TrichopoulouHellenic Health Foundation, Athens, Greece.
Rosario TuminoCancer Registry and Histopathology Department, Provincial Health Authority (ASP), Ragusa, Italy.
Tilman KühnDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Veronika FedirkoDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.ORCID 0000-0002-7805-9913
Emory University · USAmerican Cancer Society · USAarhus University · DKCentre international de recherche sur le cancer · FRGerman Cancer Research Center · DEHellenic Health Foundation · GRImperial College London · GBNational Institute for Public Health and the Environment · NLRegional Health · USUiT The Arctic University of Norway · NOUmeå University · SEUniversidad de Antioquia · COUniversity of Oxford · GB

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008169 · NIGMS · EMORY UNIVERSITY · PI GROSS, ROBERT E · 1987 to 2021
$20.3M
Biomarkers of Inflammation, Vitamin D, and Colorectal Cancer Risk and SurvivalF30CA236231 · NCI · EMORY UNIVERSITY · PI GIBBS, DAVID CORLEY · 2019 to 2022
$185k
A Pooled Analysis of 25-hydroxyvitamin D and Colorectal Cancer SurvivalR03CA183016 · NCI · EMORY UNIVERSITY · PI FEDIRKO, VERONIKA · 2014 to 2015
$173k
Cancer Research UK C570/A16491Medical Research Council 1000143Medical Research Council MR/M012190/1NCI NIH HHS F30 CA236231NCI NIH HHS R03 CA183016NIGMS NIH HHS T32 GM008169World Health Organization 001
6 · The paper itself

Abstract

Lower prediagnostic circulating 25-hydroxyvitamin D (25[OH]D)-considered the best marker of total vitamin D exposure-is associated with higher mortality risk among colorectal cancer (CRC) patients. However, it is unknown whether this association differs by the vitamin D-binding protein (GC) isoform Gc2 (encoded by GC rs4588*C>A, Thr436Lys), which may substantially affect vitamin D metabolism and modify associations of 25(OH)D with colorectal neoplasm risk. Prediagnostic 25(OH)D-mortality associations according to Gc2 isoform were estimated using multivariable Cox proportional hazards regression among 1281 CRC cases (635 deaths, 483 from CRC) from two large prospective cohorts conducted in the United States (Cancer Prevention Study-II) and Europe (European Prospective Investigation into Cancer and Nutrition). 25(OH)D measurements were calibrated to a single assay, season standardized, and categorized using Institute of Medicine recommendations (deficient [<30], insufficient [30 - <50], sufficient [≥50 nmol/L]). In the pooled analysis, multivariable-adjusted hazard ratios (HRs) for CRC-specific mortality associated with deficient relative to sufficient 25(OH)D concentrations were 2.24 (95% CI 1.44-3.49) among cases with the Gc2 isoform, and 0.94 (95% CI 0.68-1.22) among cases without Gc2 (P

Indexed as

Polymorphism, Single NucleotideAgedAged, 80 and overColorectal NeoplasmsFemaleGenetic Association StudiesHumansMaleMiddle AgedPrognosisProspective StudiesProtein IsoformsUnited StatesVitamin DVitamin D-Binding Protein25-hydroxyvitamin DGC protein, humanProtein IsoformsVitamin DVitamin D-Binding Protein25-hydroxyvitamin Dcohort studiesgene-environment interactionsingle nucleotide polymorphismsurvival analysis

Identifiers

PMID32391587
PMCPMC7529852
OpenAlexW3022052976

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.